Novozymes North America is the N.C.Department of Commerce's 6th annual N.C.International Community and Economic Development Award winner in the mid company category.

The Danish-based industrial biotechnology company was one of four finalists cited by the Commerce Department for empowering and encouraging its employees to be active in the local and regional community, for its executive leadership and commitment, and its corporate mission statement and values.

In a separate release, Secretary Jim Fain saluted the finalists for “their civic and philanthropic contributions” and for embracing “the North Carolina communities in which they do business.”

Ronnie Goswick, director of Franklin County Economic Development Commission noted, “Novozymes is a very supportive corporate citizen. Not only does the company provide monetary support and encourage their employees to volunteer in the community, they provide their facilities for public forums and leadership for education and other important public priorities.”

“Novozymes strongly believes in good corporate citizenship. Our company is dedicated to supporting the communities in which our employees live and work,” stated Thomas Nagy, president. “Novozymes encourages and supports each of our more than 400 employees at our Franklinton facility who actively commits time and financial resources to sustain organizations whose goals and values match their own,” Nagy added.

Novozymes was presented with the award during an awards luncheon hosted by the N.C.Department of Commerce in Greensboro on Nov.16 at the Koury Convention Center.

In support of the corporate social responsibility component of Novozymes’ Triple Bottom Line philosophy, employees focus on community activities that positively impact the quality of life in local areas. Primary community activities focus on humanity, education and the environment.

Novozymes, which has topped the Dow Jones Sustainability Index for the past six consecutive years, is the biotech-based world leader in enzymes and microorganisms. Using nature’s own technologies, the company continuously expands the frontiers of biological solutions to improve industrial performance everywhere. Headquartered in Denmark, Novozymes employs more than 4,000 people in 30 countries. Producing more than 100 types of enzymes and microorganisms and selling more than 600 products in 130 countries, Novozymes A/S B shares are listed on the Copenhagen Stock Exchange. The company’s regional headquarters for North America are located in Franklinton, North Carolina. For further company information, visit us at